Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence
Read More General business news Translational Development Acquisition Corp. secures $172.5m in IPO with full over-allotment exercise NEW Translational Development Acquisition Corp. has successfully closed its initial public offering (IPO), generating $172.5 million in gross… byPallavi MadhirajuDecember 25, 2024